在COVID-19治疗的随机试验中,匹配与非匹配的安慰剂
Gilmar Reis1,2,3,4, Leonardo Cançado Monteiro Savassi1,4,5, Thiago Santiago Ferreira1,4
1Research Division, Cardresearch-Cardiologia Assistencial e de Pesquisa, Belo Horizonte, Brazil.
JAMA network open
|May 20, 2024
概括
匹配的安慰剂是资源密集的. 这项研究发现,非匹配的安慰剂在COVID-19临床试验中与匹配的安慰剂没有显著不同,这表明它们可能会提高试验效率.
科学领域:
- 传染病研究 传染病研究
- 临床试验方法论 临床试验方法论
- 生物统计学 生物统计学
背景情况:
- 匹配的安慰剂干预是复杂的和资源密集的.
- 之前关于安慰剂偏差的研究主要集中在疼痛和心理健康上,对传染病的检查有限.
- 不匹配的安慰剂可能在临床试验中提供更有效的替代品.
研究的目的:
- 为了在COVID-19治疗中比较非匹配和匹配的安慰剂组之间的临床结果.
- 在传染病临床试验中评估匹配安慰剂的必要性.
- 为了评估治疗效果估计的潜在差异,使用非匹配与匹配的安慰剂.
主要方法:
- 针对COVID-19的大型,多臂,平台随机临床试验的后期分析.
- 贝叶斯和频率主义者对7个干预-安慰剂对进行协变调整技术的比较.
- 评估结果,包括住院和患者报告的生活质量得分.
主要成果:
- 一项元分析显示,非匹配与匹配的安慰剂的几率比率为1.01 (95%可信区间,0.77-1.32) 不匹配与匹配的安慰剂,表明没有显著差异.
- 后期等效概率为85.4%,支持使用非匹配的安慰剂.
- 对事件发生率和患者报告结果的未经调整的分析也显示,安慰剂组之间没有明显的差异.
结论:
- 汇集匹配和非匹配的安慰剂数据并没有在COVID-19试验药物的治疗效果估计中引入不一致.
- 使用非匹配的安慰剂可以提高统计能力,并减少平台试验中的实施障碍.
- 这些发现支持未来传染病临床试验中非匹配安慰剂的潜力.
更多相关视频
相关概念视频
Controls in Experiments
7.5K
When conducting an experiment, it is crucial to have control to reduce bias and accurately measure the dependent variables. It also marks the results more reliable. Controls are elements in an experiment that have the same characteristics as the treatment groups but are not affected by the independent variable. By sorting these data into control and experimental conditions, the relationship between the dependent and independent variables can be drawn. A randomized experiment always includes a...
7.5K
The Placebo Effect
6.1K
The placebo effect occurs when people's expectations or beliefs influence or determine their experience in a given situation. In other words, simply expecting something to happen can actually make it happen.
6.1K
Comparing the Survival Analysis of Two or More Groups
177
Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and...
177
Hazard Ratio
114
The hazard ratio (HR) is a widely used measure in clinical trials to compare the risk of events, such as death or disease recurrence, between two groups over time. It reflects the ratio of hazard rates—the instantaneous risk of the event occurring—between a treatment group and a control group. This measure provides valuable insights into the relative effectiveness of a treatment by assessing how the risk of an event differs between the two groups.
For example, in a clinical trial...
For example, in a clinical trial...
114
Multiple Comparison Tests
3.9K
Multiple comparison test, abbreviated as MCT, is a post hoc analysis generally performed after comparing multiple samples with one or more tests. An MCT will help identify a significantly different sample among multiple samples or a factor among multiple factors.
It would be easy to compare two samples using a significance alpha level of 0.05. In other words, there is only one sample pair to be compared. However, it would be difficult to identify a significantly different sample if the number...
It would be easy to compare two samples using a significance alpha level of 0.05. In other words, there is only one sample pair to be compared. However, it would be difficult to identify a significantly different sample if the number...
3.9K


